De-escalated therapy for HR+/HER2+ breast cancer patients...

  • Main
  • 2019 / 02
  • De-escalated therapy for HR+/HER2+ breast cancer patients...
Annals of Oncology 2019 / 02

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2 weeks letrozole: results of the PerELISA neoadjuvant study

Guarneri, V, Dieci, M V, Bisagni, G, Frassoldati, A, Bianchi, G V, De Salvo, G L, Orvieto, E, Urso, L, Pascual, T, Paré, L, Galván, P, Ambroggi, M, Giorgi, C A, Moretti, G, Griguolo, G, Vicini, R, Pra
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz055
Date:
February, 2019
File:
PDF, 522 KB
english, 2019
Conversion to is in progress
Conversion to is failed